Mechanism, symptoms and diagnosis of COVID-19

-

The research found that angiotensin‐converting enzyme 2 (ACE2) was the receptor for SARS‐CoV‐2. In the normal human lung, ACE2 is expressed on type I and II alveolar epithelial cells. Among them, 83% of the type II alveolar cells have ACE2 expression. Men had a higher ACE2 level in their alveolar cells than women. Asians have a higher level of ACE2 expression in their alveolar cells than the White and African American populations. The binding of SARS‐CoV‐2 on ACE2 causes an elevated expression of ACE2, which can lead to damages on alveolar cells. Damages to alveolar cells can, in turn, trigger a series of systemic reactions and even death. The research also confirmed that Asian males are more susceptible to SARS‐CoV‐2 infection. The receptor‐binding ability of SARS‐CoV‐2 is 10 to 20 times stronger than that of SARS‐CoV.

Scientists found that 98% of the patients in their study had fevers, of which 78% had a temperature higher than 38°C. They reported that 76% of the patients had coughs, 44% of patients experienced fatigue and muscle pain, and 55% of patients had dyspnea. A small number of patients also developed expectoration (28%), headaches (8%), hemoptysis (5%), and diarrhea (3%). Laboratory tests found that 25% of infected patients had leukopenia and 63% had lymphocytopenia. The level of aspartate aminotransferase was elevated in 37% of the patients. Myocarditis was diagnosed in 12% of the patients, and the level of hypersensitive troponin I was significantly increased in these patients. Abnormalities in chest computed tomography (CT) images were found in 100% of the patients. Grinding glass‐like and consolidation areas were found in 98% of the infected patients' bilateral lungs.

Zhu reported three cases of COVID‐19. Patient 1 was a 49‐year‐old female with a fever (body temperature 37 to 38°C) and had coughs accompanied by chest discomfort. Four days after the onset of the disease, her coughs and chest discomfort aggravated, but her fever subsided. Patient 2, a 61‐year‐old male, also developed fevers and coughs at the initial stage of the disease. Respiratory distress appeared 7 days after the onset of symptoms and worsened within the next 2 days. He was treated with mechanical ventilation. Patient 3 was a 32‐year‐old male whose symptoms were not described in the article. Patients 1 and 3 recovered and were discharged from hospital after treatment, but patient 2 died after 20 days of treatment.

Guan reported 1099 cases of 2019‐nCoV infection. They found that fevers (87.9%) and coughs (67.7%) were the most common symptoms. Diarrhea (3.7%) and vomiting (5.0%) were rare. Abnormalities in chest CT images were found in 96% of the SARS‐CoV‐2‐infected patients, and lymphopenia was observed in 82.1% of them.

Comments

Post a Comment

Popular posts from this blog

Carbonic anhydrase inhibitors (Acetazolamide)

-
Image
Carbonic anhydrase inhibitors Overview: Acetazolamide, the prototype Carbonic Anhydrase Inhibitors, inhibits carbonic anhydrase and in doing so reduces renal bicarbonate resorption in the proximal tubule. This leads to a direct increase in urinary bicarbonate excretion and secondarily to mild increases in sodium and potassium excretion. Because of its mild effects on electrolytes acetazolamide is a largely safe drug with few adverse side effects but in consequence is rarely used for its diuretic capacity. Mechanism of action: Effects on Bicarbonate:  The pharmacological effects of acetazolamide are due to its inhibitory effect on carbonic anhydrase in the proximal tubule. As discussed in R enal Bicarbonate Excretion , luminal and intracellular pools of carbonic anhydrase in the proximal tubule are critical for resorbing filtered bicarbonate and thus administration of acetazolamide results in significant increases in renal bicarbonate excretion. Because bicarbonate acts a
Read more

THE IMMUNE SYSTEM NEW DEVELOPMENTS IN RESEARCH PART 1

-
Image
INTRODUCTION TO IMMUNOLOGY Hello, I am Gajendra Choudhary , welcome to my new blog, The Immune System, New Developments in Research. Do you know how your own body protects you from viruses and other pathogens? Would you be surprised to hear that cancer may also be controlled by your immunity? Every day immunology research aims to understand the mysteries of our bodies and seeks out the seeds for medical application. This course introduces wide ranging content in general immunology fields from basic knowledge to front line research. In particular, I hope that from this course you gain necessary understanding of the new world of immunology, the world opened up by the illustrious immunologists of the past, and the unexplored mysteries that are yet to be explained by experiencing a part of the front line research currently in progress. In this series, we will be learning how the immune system works, in particular how the components of the immune system interact with each other, and
Read more

GLYCOLYSIS

-
Image
GLYCOLYSIS The official spokesperson of carbohydrate metabolism ,'glucose', speaks: "I burn myself to provide fuel to life! Generated through gluconeogenesis by my friends; Engaged in the synthesis of lipids, amini acids; Deranged in my duties due to diabetes melitus." INTRODUCTION Glycolysis is derived from the Greek words (g;lycose- sweet or sugar; lysis -dissolution). Universal pathway in the living cells. This pathway is often referred to as Embden Meyerhof pathway (E.M. pathway). Definition:  Glycolysis is defined as the sequence of reactions converting glucose(or glycogen) to pyruvate or lactate, with the production of ATP. what i am gonna do now is try to make it more interesting for you guys to understand this topic.. it will be a brief conversation between 2 people so lets see how it goes. Fun way to understand glycolysis The conversation between two people to make you guys understand glycolysis more efficiently.
Read more